找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders; Shabir Ahmad Ganai Book 2019 Springer Nature Singapore Pte Ltd. 2019

[复制链接]
楼主: Radiofrequency
发表于 2025-3-23 13:43:03 | 显示全部楼层
Current Challenges with HDAC Inhibitor-Based Therapeutic Intervention Against Neurological Maladiesand high structural identity at the active sites of different HDACs. Importantly, the lack of blood-brain barrier permeability of HDACi restricting the use of these marvellous inhibitors against neurological disorders is detailed.
发表于 2025-3-23 14:58:07 | 显示全部楼层
rders.It uniquely highlights the potential of various HDAC i.This book provides an outline of epigenetics as a whole, while also specifically examining a range of epigenetic players, including histone acetyl transferases (HATs) and histone deacetylases (HDACs). It chiefly focuses on the emerging tar
发表于 2025-3-23 21:15:14 | 显示全部楼层
发表于 2025-3-24 01:48:14 | 显示全部楼层
Different Groups of HDAC Inhibitors Based on Various Classifications,n and source. Further, the detailed account of various approved HDACi for treating various malignancies will be given. Notably, I will discuss the different structural components of a typical HDAC inhibitor.
发表于 2025-3-24 03:46:20 | 显示全部楼层
HDAC Inhibitors as Novel Therapeutic Option Against Therapeutically Challenging Neurological Disordfect of various HDACi against neurological disorders including Alzheimer’s disease, Parkinson’s disease, and epilepsy. The underlying molecular players modulated by these inhibitors in bringing therapeutic effect will also be taken into consideration.
发表于 2025-3-24 08:50:50 | 显示全部楼层
发表于 2025-3-24 12:56:45 | 显示全部楼层
发表于 2025-3-24 16:54:59 | 显示全部楼层
Epigenetics and its Implications in Neurological Disorders,one proteins undergo. Moreover, the altered activity and expression of various epigenetic enzymes in distinct neurological disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS) will be thoroughly discussed.
发表于 2025-3-24 23:00:02 | 显示全部楼层
Designing of Selective and Brain-Penetrant HDAC Inhibitors for Effective Therapy Against Neurologiccomputational and medicinal chemistry approaches for designing selective HDAC inhibitors. Further, the chapter also gives bird’s eye view on image-guided approach for identifying the brain-penetrant HDACi.
发表于 2025-3-25 02:40:23 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-10 14:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表